CH Biotech R&D CoTPE:6534 +0.11%84 PEG Ratio is 0.88 as of Jul. 06, 2026, which is 2% below its 10-year median of 0.90. GuruFocus rates TPE:6534 with a GF Score™ of 84/100 and a GF Value™ of NT$100.55 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 109 Agriculture companies, CH Biotech R&D Co ranks better than 69.72% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for CH Biotech R&D Co's PEG Ratio or its related term are showing as below:
TPE:6534'
s PEG Ratio Range Over the Past 10 Years
Min: 0.72 Med: 0.9 Max: 2.28
Current: 0.88
During the past 13 years, CH Biotech R&D Co's highest PEG Ratio was 2.28. The lowest was 0.72. And the median was 0.90.
TPE:6534's PEG Ratio is ranked better than 69.72% of 109
companies
in the Agriculture industry
Industry Median: 1.43
vs TPE:6534: 0.88
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
CH Biotech R&D Co (TPE:6534) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
CH Biotech R&D Co PEG Ratio Related Terms
CH Biotech R&D Co PEG Ratio Historical Data
* Premium members only.
The historical data trend for CH Biotech R&D Co's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Agricultural Inputs subindustry, CH Biotech R&D Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CH Biotech R&D Co PEG Ratio vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, CH Biotech R&D Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where CH Biotech R&D Co's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
CH Biotech R&D Co (TPE:6534) has a PEG Ratio of 0.88 as of Jul. 06, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on CH Biotech R&D Co and its competitors. This is near median its historical median of 0.90. Over the past decade, CH Biotech R&D Co's PEG Ratio has ranged from 0.72 to 2.28. According to the industry distribution chart, CH Biotech R&D Co ranks #33 out of 109 companies in the Agriculture industry, placing it in the top 30.3%.
Is CH Biotech R&D Co's PEG Ratio too high?
CH Biotech R&D Co's current PEG Ratio of 0.88 is near median its 10-year median of 0.90. Over the past 10 years, this metric has ranged from a low of 0.72 to a high of 2.28. The Agriculture industry median PEG Ratio is 1.43. CH Biotech R&D Co's value of 0.88 is 38.5% below this industry median. Based on the distribution chart, CH Biotech R&D Co ranks #33 out of 109 companies in the Agriculture industry, which is above the industry midpoint. Overall, CH Biotech R&D Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CH Biotech R&D Co's PEG Ratio compare to CTVA and CF?
According to the Agriculture industry distribution chart, CH Biotech R&D Co ranks #33 out of 109 companies for PEG Ratio. This puts CH Biotech R&D Co in the upper half of its industry. The industry median PEG Ratio is 1.43. CH Biotech R&D Co's value of 0.88 is 38.5% below this benchmark. Historically, CH Biotech R&D Co's own PEG Ratio has ranged from 0.72 to 2.28 over the past decade. While the company's 10-year median is 0.90 vs. the industry median of 1.43, CH Biotech R&D Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for an Agriculture company?
The median PEG Ratio among Agriculture companies is 1.43, based on 109 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CH Biotech R&D Co's current PEG Ratio of 0.88 is 38.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on CH Biotech R&D Co and its competitors. For the Agriculture industry, the median PEG Ratio is 1.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CH Biotech R&D Co's current PEG Ratio is 0.88, which is near median its own 10-year median of 0.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CH Biotech R&D Co stock overvalued right now?
Based on GuruFocus' analysis, CH Biotech R&D Co (TPE:6534) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$100.55, compared to a current price of NT$90.20 — trading 10.3% below its estimated fair value. The current PEG Ratio is 0.88, which is near median its 10-year median of 0.90 and 38.5% below the Agriculture industry median of 1.43. CH Biotech R&D Co's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For CH Biotech R&D Co (TPE:6534), the current PEG Ratio is 0.88 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CH Biotech R&D Co (TPE:6534) Overvalued in 2026?
Based on GuruFocus' analysis, CH Biotech R&D Co stock appears to be undervalued.
The current stock price of NT$90.20 is trading 10.3% below its estimated GF Value™ of NT$100.55.
GuruFocus considers CH Biotech R&D Co to be Modestly Undervalued.
Key valuation signals for TPE:6534:
PEG Ratio: 0.88 (near median its 10-year median of 0.90)
GF Value™: NT$100.55 vs. price of NT$90.20 (10.3% below fair value)
Industry Position: 38.5% below the Agriculture median (#33 of 109)
No single metric tells the full story. See the TPE:6534 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CH Biotech R&D Co Ltd is a Taiwan-based company engaged in the manufacture and sales of fertilizer, as well as providing biotechnology services. It is engaged in the research, development, manufacturing, and sales of proprietary plant growth regulators and specialty micronutrient fertilizers. It offers NutriSync 3D plant growers in the form of boron and molybdenum, NutriSync D liquid formulation for dicot crops, CHB-HS for reducing carbon emissions in crop production, CHB-BB2, fruit quality enhancers, and other related products. The company has one reportable segment, Agricultural Biotechnology. Geographically, it derives maximum revenue from the United States, and the rest from other countries.
84GF Score
Get the complete analysis for TPE:6534
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6534 has been successfully added to your 
